Skip to main content

Table 3 Relationship between MVI severity and HBV-related factors (The HBsAg factor included all 660 patients, and other factors included only HBsAg-positive patients)

From: Effect of hepatitis B virus DNA replication level and anti-HBV therapy on microvascular invasion of hepatocellular carcinoma

HBV-related factors

Severity of MVI

P

M0 (%)

M1 (%)

M2 (%)

HBsAg

Positive

297 (84.6)

155 (88.6)

126 (94.0)

0.017

Negative

54 (15.4)

20 (11.4)

8 (6.0)

HBV DNA

> 100 IU/ml

145 (48.8)

82 (52.9)

84 (68.3)

0.001

<=100 IU/ml

152 (51.2)

73 (47.1)

39 (31.7)

Presence of cirrhosis

Yes

191 (64.3)

124 (0.80)

77 (62.6)

0.001

No

106 (35.7)

31 (0.20)

46 (37.4)

Antivirus treatment

Yes

102 (34.3)

41 (26.4)

31 (25.2)

0.021

No

195 (65.7)

114 (73.6)

92 (74.8)